C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
12/2004
12/16/2004	US20040254116 Contactor tissue with transforming growth factor kinase receptors; modulate cell proliferation
12/16/2004	US20040254114 Genetic engineering
12/16/2004	US20040254110 Methods for diagnosing and treating Alzheimer's disease
12/16/2004	US20040254106 Modified factor ix
12/16/2004	US20040254105 recombinant vectors and recombinant host cells
12/16/2004	US20040253731 Solution comprising surfactant, hydrophobic phase and hydrophilic phase comprising plurality of microcapsules containing functional in vitro eukaryotic expression system for transfer of heterologous into cells
12/16/2004	US20040253709 Schistosoma protein for use in treatment of organ-specific autoimmune diseases
12/16/2004	US20040253704 Plasmid comprising nucleotide sequences coding poly- gamma -glutamate synthetase for use in developing vaccine for prevention and treatment of bacillus infection
12/16/2004	US20040253686 Novel human kunitz-type inhibitors and methods relating thereto
12/16/2004	US20040253684 Nucleotide sequences coding mambrane associated guanylate kinase for use in treatment and prevention of nervous system, blood, sleep and behavioral disorders
12/16/2004	US20040253682 Immunloglobulin prostaglandin inhibitor for use in the treatment and prevention of arthritic and inflammatory bowel disorders
12/16/2004	US20040253678 Novel collagen production method
12/16/2004	US20040253674 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR)
12/16/2004	US20040253671 Isolating hexose oxidase for use as tool in enhancement of nutrient quality of animal feeeds
12/16/2004	US20040253667 Expression vector comprising nuclelotide sequences coding membrane protein for use in identifying modulator for treatment of cell proliferative, nervous system and inflammatory diseases
12/16/2004	US20040253666 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/16/2004	US20040253665 Novel peptide-producing enzyme, microbe producing the enzyme and method for dipeptide synthesis using them
12/16/2004	US20040253655 Immunoassay for use in detection high blood pressure; immunodiagnostics
12/16/2004	US20040253651 Detected from secreted glycoprotein (such as matrix metalloproteinases, prostate specific antigen, kallikrein 2, human chorionic gonadotrophin or carcinoembryonic antigen); glycosyltransferases; for diagnosing and targeting cell proliferative disorders; vaccines
12/16/2004	US20040253623 Nucleic acid binding proteins
12/16/2004	US20040253619 Methods for rapid detection and identification of bacterial bioagents
12/16/2004	US20040253612 Selection of proteins using RNA-protein fusions
12/16/2004	US20040253610 Expression vector comprising nucleotide sequences coding tumor necrosis factor receptor protein (TWEAK) for use in identifying modulators for treatment of inflammatory, cardiovacullar, vision and cancer disorders
12/16/2004	US20040253597 Sodium dependent dicarboxylate transport protein for use in identifying modulators for prevention/treatment of hepatic, prostate, splenic, renal diseases, metabolic, circulatory, cancer and aging disorders
12/16/2004	US20040253595 P53-dependent apoptosis-inducing protein and method of screening for apoptosis regulator
12/16/2004	US20040253588 Cytochrome p450 monooxygenase for use in identifying modulators for treatment, diagnosis and prevention of autoimmune/inflammatory, cell proliferative, developmental, endocrine, eye, metabolic, gastrointestinal and liver disorders
12/16/2004	US20040253583 Methods for rapid detection and identification of viral bioagents
12/16/2004	US20040253270 Nucleic acid encoding infectious, nonpathogenic porcine circovirus type-1(PCV1), which contains immunogenic open reading frame gene of pathogenic PCV2 in place of an ORF gene of PCV1 nucleic acid molecule; means of protecting pigs against viral infection or postweaning multisystemic wasting syndrome
12/16/2004	US20040253240 immunogens used to induce immune response against specific epitopes of apolipoproteins; prophylaxis of atherosclerosis; immunotherapy
12/16/2004	US20040253234 DNA sequences that code antibodies or fragments; genetic vectors and host cells transformed by the vector, used for diagnosis and prophylaxis of cancer
12/16/2004	US20040253233 genetic engineered chimeric and humanized antibodies obtained from murine monoclonal antibody P3 (MAb P3) and its antiidiotypic antibodies, used as antitumor agents
12/16/2004	US20040253231 monoclonal or polyclonal antibodies having specific reactivity with adenosine triphosphate binding domains, caspase recruitment domains and triosephosphate isomerase domain peptides, used for modulation of apoptosis
12/16/2004	CA2531569A1 Composition for stabilizing survival of transplanted hematopoietic stem cell, kit for obtaining the composition, method of stabilizing survivial of transplanted hematopoietic stemcell, human monoclonal antibody or human polyclonal antibody and method of producing the same, gene encoding human monoclonal antibody and transformation introducing the gene
12/16/2004	CA2525975A1 Humanized antibodies that recognize beta amyloid peptide
12/15/2004	EP1486571A1 Method for the recombinant production of polypeptides
12/15/2004	EP1486511A1 Refolding of polypeptides
12/15/2004	EP1486508A1 Use of the AL-1 neurotrophic factor, a ligand for an EPH-related tyrosine kinase receptor, for the preparation of a medicament for modulating angiogenesis associated disease or condition
12/15/2004	EP1485492A2 Gntiii (udp-n-acetylglucosamine:beta-d mannoside beta(1,4)-n-acetylglucosaminyltransferase iii) expression in plants
12/15/2004	EP1485486A2 Optimizing glycan processing in plants
12/15/2004	EP1485481A2 Fluorescent protein from aequorea coerulescens and uses thereof
12/15/2004	EP1485477A2 Novel type-1 cytokine receptor glm-r
12/15/2004	EP1485404A2 Novel glucose 6-oxidases
12/15/2004	EP1485397A2 Trans-splicing mediated imaging of gene expression
12/15/2004	EP1485130A2 Reagents and treatment methods for autoimmune diseases
12/15/2004	EP1485108A2 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression
12/15/2004	EP1485075A2 Mhc-peptide complex binding ligands
12/15/2004	EP1484959A2 Nucleic acid constructs and methods for producing altered seed oil compositions
12/15/2004	EP1453954A4 Endocrine pancreas differentiation of adipose tissue-derived stromal cells and uses thereof
12/15/2004	EP1212358B1 Synthetic papillomavirus genes optimized for expression in human cells
12/15/2004	EP1121448B1 EXPRESSION AND SECRETION OF icIL-1 RECEPTOR ANTAGONIST TYPE II
12/15/2004	EP1116029A4 Apoptosis marker antibodies and methods of use
12/15/2004	EP1025211B1 Hyaluronan synthase gene and uses thereof
12/15/2004	EP0968290B1 Anti-alphavbeta3 humanized monoclonal antibodies
12/15/2004	EP0956304B1 Dendritic cell-specific antibodies
12/15/2004	EP0850310B1 Circular dna molecule with conditional origin of replication, method for preparing same and use thereof in gene therapy
12/15/2004	EP0773996B1 INTERRUPTION OF BINDING OF MDM2 AND p53 PROTEIN AND THERAPEUTIC APPLICATION THEREOF
12/15/2004	EP0638088B1 Hybrid human/porcine factor viii
12/15/2004	CN1555412A Aminopeptidase
12/15/2004	CN1555411A Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
12/15/2004	CN1555393A Keratin-based products and methods for their production
12/15/2004	CN1555268A Therapeutic agents comprising pro-apoptotic proteins
12/15/2004	CN1554664A Compounds and methods for diagnosis of tuberculosis
12/15/2004	CN1554257A Sea Aceta chinensis high value ecolugical utilizing process
12/15/2004	CN1180083C Cytochrome C and its gene
12/15/2004	CN1180080C Preprartion method of improved hepatoma murine monoclonal antibody
12/15/2004	CN1179976C Method for producing blood coagulation factor VIII host cell
12/15/2004	CN1179975C Scorpion peptide for treating arrhythmia and its preparing process and application
12/14/2004	US6831167 Mutants of the factor VII-activating protease and detection methods using specific antibodies
12/14/2004	US6831159 Method for purifying factor VIII/vWF company by cation-exchange chromatography
12/14/2004	US6831157 Process for the purification of serum albumin
12/14/2004	US6831153 Nucleotide sequences for use in the diagnosis and treatment of psychological disorders
12/14/2004	US6831152 Colon specific genes and proteins
12/14/2004	US6831151 Mast cell-specific signal transducing molecules and cDNAs thereof
12/14/2004	US6831060 Nucleotide sequences coding erythropoietin protein for use in the treatment of blood disorders
12/14/2004	US6830924 For anticarcinogenic drugs; kits
12/14/2004	US6830917 Method of isolation and purification of trypsin from pronase protease and use thereof
12/14/2004	US6830914 RGS-containing molecules and uses thereof
12/14/2004	US6830913 ABCB9 transporter and uses thereof
12/14/2004	US6830901 Propionibacteruim vector
12/14/2004	US6830895 Method and kit for typing feline blood
12/14/2004	US6830751 Use of IL-12 antagonists in the treatment of rheumatoid arthritis
12/14/2004	CA2180555C Radiolabeled annexins
12/14/2004	CA2169355C Tumor suppressor protein prb2, related gene products, and dna encoding therefor
12/14/2004	CA2104957C Redirection of cellular immunity by receptor chimeras
12/14/2004	CA1341468C Preparation of functional human factor viii
12/09/2004	WO2004106525A1 A fusion protein suitable to be expressed high effectively and the production method thereof
12/09/2004	WO2004106514A1 Method of recovering protein by deubiquitinating ubiquitinated protein
12/09/2004	WO2004106508A2 Bioreactor containing cells expressing glycosyltransferase nucleic acids
12/09/2004	WO2004106382A1 Antibody and use thereof
12/09/2004	WO2003080808A3 Novel compositions and methods in cancer
12/09/2004	WO2003074726A3 Immune response associated proteins
12/09/2004	WO2003062382A3 Methods to identify evolutionarily significant changes in polynucleotide and polypeptide sequences in domesticated plants and animals
12/09/2004	WO2003056897A3 Highly phosphorylated acid beta-glucocerebrosidase and methods of treating gaucher's disease
12/09/2004	WO2003014142A3 Phosphorylated histone h2b as an apoptosis marker
12/09/2004	WO2002090300A3 Nucleic acids and proteins with thioredoxin reductase activity
12/09/2004	US20040250304 Novel collagen-like protein clac, precussor thereof and genes encoding the same
12/09/2004	US20040250300 Expression of proteins in milk
12/09/2004	US20040250241 System and method for dynamic data binding in distributed applications
12/09/2004	US20040249143 Hagfish cathelin-associated antimicrobial peptides and genes
12/09/2004	US20040249139 Nucleotide sequences coding transmembrane cochlear-expressed gene 1(TDC1) protein for use in diagnosis, prognosis and treatment of hearing loss

1 ... 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 ... 1125